Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

3.4K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

13.8K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
13.8K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

6.1K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.1K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

10.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
10.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

UCL Queen Square Institute of Neurology: 75 years of innovation.

The Lancet. Neurology·2026
Same author

Emerging therapeutic strategies for mitochondrial DNA-related diseases.

Cell reports. Medicine·2026
Same author

COXFA4L2 upregulation preserves residual cytochrome c oxidase activity in COXFA4-related Leigh-like encephalopathy.

Nature communications·2026
Same author

Mavodelpar in patients with primary mitochondrial myopathy: a phase 1 trial.

Scientific reports·2026
Same author

Diagnostic Criteria and Management of MELAS and Stroke-Like Episodes: Consensus-Based Statements.

European journal of neurology·2026
Same author

Intersection of Spinal Muscular Atrophy and Progressive Myoclonic Epilepsy Syndrome: ASAH1 Gene.

Annals of Indian Academy of Neurology·2026

Related Experiment Video

Updated: May 29, 2025

Author Spotlight: Decoding Mitochondrial Aging
08:48

Author Spotlight: Decoding Mitochondrial Aging

Published on: June 30, 2023

3.5K

Activating AMPK improves pathological phenotypes due to mtDNA depletion.

Gustavo Carvalho1, Tran V H Nguyen1, Bruno Repolês1

  • 1Department of Medical Biochemistry and Biophysics, Umeå University, Umeå, Sweden.

The FEBS Journal
|February 7, 2025
PubMed
Summary

AMP-activated protein kinase (AMPK) activation occurs early in mitochondrial dysfunction, even before energy levels drop. Stimulating AMPK with A-769662 improved mitochondrial function and partially restored DNA levels in disease models.

Keywords:
AMPKAMP‐activated protein kinasemitochondrial DNA depletionpolymerase ɣ

More Related Videos

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.5K
Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

11.6K

Related Experiment Videos

Last Updated: May 29, 2025

Author Spotlight: Decoding Mitochondrial Aging
08:48

Author Spotlight: Decoding Mitochondrial Aging

Published on: June 30, 2023

3.5K
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.5K
Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

11.6K

Area of Science:

  • Cellular Biology
  • Mitochondrial Biology
  • Metabolic Regulation

Background:

  • AMP-activated protein kinase (AMPK) regulates cellular energy and mitochondrial health.
  • The threshold for AMPK activation during mitochondrial dysfunction is unknown.
  • The therapeutic potential of AMPK activation in mitochondrial disease requires investigation.

Purpose of the Study:

  • To determine the onset of AMPK activation during mitochondrial dysfunction.
  • To investigate if AMPK activation can ameliorate mitochondrial disease phenotypes.
  • To explore the impact of AMPK agonists on mitochondrial DNA (mtDNA) levels.

Main Methods:

  • Utilized a cellular model of progressive mtDNA depletion and mitochondrial dysfunction.
  • Monitored AMPK activation relative to ATP/(AMP+ADP) ratio and respiratory chain activity.
  • Administered the AMPK agonist A-769662 to disease models and control cells.
  • Assessed mitochondrial membrane potential and mtDNA levels post-treatment.

Main Results:

  • Mitochondria-associated AMPK activation preceded significant drops in cellular energy and respiratory function.
  • A-769662 treatment restored mitochondrial membrane potential in disease models.
  • A-769662 partially rescued mtDNA levels in cells with severe depletion.
  • Beneficial effects on mitochondrial membrane potential were observed in patient-derived cells.

Conclusions:

  • AMPK activation is an early event in mitochondrial dysfunction.
  • AMPK agonists show promise in treating mitochondrial diseases linked to mtDNA depletion.
  • Targeting AMPK may offer a therapeutic strategy for mitochondrial disorders.